<?xml version="1.0"?>
<template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
  <id>c49b96bb-2de0-4d9c-abf9-24088962a440</id>
  <name>Biologic Medications for GI Patients Pediatric Order Set</name>
  <description>
    <lifecycle_state>Initial</lifecycle_state>
    <details>
      <purpose/>
      <use/>
      <misuse/>
    </details>
    <other_details>
      <item>
        <key>MetaDataSet:Sample Set </key>
        <value>Template metadata sample set </value>
      </item>
      <item>
        <key>Acknowledgements</key>
        <value/>
      </item>
      <item>
        <key>Business Process Level</key>
        <value/>
      </item>
      <item>
        <key>Care setting</key>
        <value/>
      </item>
      <item>
        <key>Client group</key>
        <value/>
      </item>
      <item>
        <key>Clinical Record Element</key>
        <value/>
      </item>
      <item>
        <key>Copyright</key>
        <value/>
      </item>
      <item>
        <key>Issues</key>
        <value/>
      </item>
      <item>
        <key>Owner</key>
        <value/>
      </item>
      <item>
        <key>Sign off</key>
        <value/>
      </item>
      <item>
        <key>Speciality</key>
        <value/>
      </item>
      <item>
        <key>User roles</key>
        <value/>
      </item>
    </other_details>
  </description>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]">
    <items>
      <item>
        <key>Technical.ï»© Technical Traceability</key>
        <value>{~AHSID~c49b96bb-2de0-4d9c-abf9-24088962a440~NAME~Biologic Medications for GI Patients Pediatric Order Set}</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vital Signs&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Vital Signs; for Standard Infusion inFLIXimab (Inflectra, Remicade, and Renflexis), Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Complete vital signs with blood pressure after each rate change and every 30 minutes at maximum rate.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vital Signs&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Vital Signs; for Rapid Infusion inFLIXimab (Inflectra, Remicade, and Renflexis), Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Complete vitals signs with blood pressure prior to commencement of the infusion and again at the end of the infusion.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vital Signs&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Vital Signs; for adalimumab, Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Complete vital signs with blood pressure prior to the administration of adalimumab.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vital Signs&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Vital Signs; for ustekinumab, Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Complete vital signs with blood pressure prior to commencement of the IV/SC treatment and again at the end of the IV/SC treatment.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vital Signs&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Vital Signs; for vedolizumab, Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Complete vitals signs with blood pressure prior to commencement of the infusion and again at the end of infusion.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Patient Care&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vital Signs&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Vital Signs; if the patient had a previous infusion reaction, Per protocol&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Blood pressure, temperature, pulse. Frequency: prior to the infusion and every 15 minutes during infusion&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Hematology&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;CBC and Differential; Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Hematology&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Erythrocyte Sedimentation Rate (ESR); Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Chemistry&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;C-Reactive Protein (CRP); Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Chemistry&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Albumin; Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Chemistry&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Alanine Aminotransferase (ALT); Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Chemistry&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Aspartate Aminotransferase (AST); Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Chemistry&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Alkaline Phosphatase (ALP); Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Chemistry&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Gamma Glutamyl Transferase (GGT); Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Chemistry&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Bilirubin, Total and Conjugated; Once&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Therapeutic Drug Monitoring and Toxicology&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Adalimumab Level (Referred Test); Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;-Contact Pediatric GI Nurse to ensure paper requestion supplied by the manufacturer is completed and sent with specimen&lt;br&gt;- Collect prior to subcutaneous injection&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Therapeutic Drug Monitoring and Toxicology&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Infliximab Level; Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;&lt;span style=&quot;background-color:#f1c40f&quot;&gt;typo in the build here that needs to be fixed (repeat in comments)&lt;/span&gt;&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;-What is the indication for testing?&lt;/p&gt;&lt;p&gt;-Collect prior to infusion&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Laboratory Investigations - Routine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Therapeutic Drug Monitoring and Toxicology&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Ustekinumab (Referred Test); Once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;- Contact Pediatric GI Nurse to ensure paper requestion supplied by the manufacturer is completed and sent with specimen&lt;br&gt;- To be done every third visit&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pediatric Topic Anesthetic Agents&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;table cellpadding=&quot;1&quot; cellspacing=&quot;1&quot; border=&quot;1&quot; style=&quot;width:500px&quot;&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td&gt;Agent&lt;/td&gt;&lt;td&gt;&lt;p&gt;Indications for Use&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;4% tetracaine gel (Ametop)&lt;/td&gt;&lt;td&gt;Wait time 30-45 minutes&lt;br&gt;Contraindications:&lt;ul&gt;&lt;li&gt;&amp;nbsp;Need urgent access&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;EMLA&lt;/td&gt;&lt;td&gt;Wait time 45-60 minutes&lt;br&gt;Contraindications:&lt;ul&gt;&lt;li&gt;Need urgent access&lt;/li&gt;&lt;li&gt;Prone to methemoglobinemia (i.e. G6PD deficiency)&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td&gt;Maxilene&lt;/td&gt;&lt;td&gt;Wait time 30 minutes&lt;ul&gt;&lt;li&gt;Safe for infants delivered at 37 weeks or greater or infants two weeks of age&lt;/li&gt;&lt;/ul&gt;&lt;p&gt;Contraindications:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Need urgent access&lt;/li&gt;&lt;li&gt;&amp;nbsp;Allergy to lidocaine&lt;/li&gt;&lt;/ul&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pediatric Topic Anesthetic Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;tetracaine Gel 4%; For ages 1 month of age and up&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;1 application, topical, once,&amp;nbsp;Apply 1/2 tube directly over vein and cover with occlusive dressing for 30 to 45 minutes pre-procedure&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pediatric Topic Anesthetic Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lidocaine-prilocaine Cream 2.5%-2.5% (Emla); For ages 3 months of age and up&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;1 application, topical, once,&amp;nbsp;Apply directly over vein and cover with occlusive dressing for 45 to 60 minutes pre-procedure&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pediatric Topic Anesthetic Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lidocaine, liposomal Cream 4%; For infants 1 month to 3 years of age&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;1 application, topical, once,&amp;nbsp;Apply 1/5th tube or 2 cm length of cream per site (equals 1 gram per site), May be applied to two sites directly over veins and covered with an occlusive dressing for 30 minutes prior to procedure.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pediatric Topic Anesthetic Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;lidocaine, liposomal Cream 4%; For children age 4 years and up&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;1 application, topically, once,&amp;nbsp;pply 1/2 tube of cream per site (equals 2.5 grams per site), May be applied to two sites directly over veins and covered with an occlusive dressing for 30 minutes prior to procedure.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pediatric Topic Anesthetic Agents&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;sucrose Oral liquid 24%; for ages 0 to four months&apos;]/activities[at0001]">
    <items>
      <item>
        <key>Transform.Technical Notes</key>
        <value>&lt;p&gt;&lt;span style=&quot;background-color:#f1c40f&quot;&gt;can we default the route of buccal here?&lt;/span&gt;&lt;/p&gt;</value>
      </item>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;2 mL, bucall, once, as needed,&amp;nbsp;Oral sucrose shall not exceed five (5) doses in 24 hours.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Fluids/Electrolytes&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pediatric Topic Anesthetic Agents&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Consider ordering the below pre-medications prior to the biologic medication administration if there was a previous reaction prescribed Biologic medications.&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;acetaminophen&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;acetaminophen&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetaminophen liquid oral; *** mg/kg/dose, oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;acetaminophen&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;acetaminophen Tablet; *** mg/kg/dose, oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Corticosteroids&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;diphenhydrAMINE&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;diphenhydrAMINE&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;diphenhydrAMINE injection; *** mg (1 mg/kg/dose), intravenous, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration.&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;diphenhydrAMINE&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;diphenhydrAMINE Capsule; *** mg (25 mg/kg/dose), oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration.&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;cetirizine&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Dosing guidance:&amp;nbsp;&lt;br&gt;Infants greater than or equal to 6 months and Children less than 2 years: Oral: 2.5 mg once.&lt;br&gt;Children 2 to 5 years: Oral 2.5 to 5 mg once.&lt;br&gt;Children greater than or equal to 5 years and Adolescents: Oral: 5 to 10 mg once.&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Pre-Medications for Biologic Infusions&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;cetirizine&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;inFLIXimab (Inflectra, Renflexis and Remicade) is restricted to be prescribed in consultation with specialistsâ expertise in the treatment of these disorders, e.g., gastroenterologists, internists.&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;br&gt;inFLIXimab (Inflectra, Remicade and Renflexis) is restricted to the treatment of moderate to severely active Crohn&apos;s Disease or ulcerative colitis in pediatric patients, subject to Specialized High-Cost Drug Program criteria of use. All other adult or pediatric indications must have STEDT approval prior to dispensing.&lt;br&gt;&amp;nbsp;&lt;br&gt;Inflectra and Renflexis are biosimilar products available on formulary and are the products of first choice for new starts of therapy in all indications.&lt;br&gt;&amp;nbsp;&lt;br&gt;Serious anaphylactic reactions are a contraindication to further use of the drug. However, people with milder reactions may receive pre-medications to lessen or prevent reactions in response to subsequent drug administration.&lt;br&gt;&amp;nbsp;&lt;br&gt;Most acute reactions occur within the first few hours of administration and are non-IgE mediated anaphylactic type reactions. Rare allergic reactions have also been reported. Delayed hypersensitivity reactions may occur 1 to 14 days after the infusion.&lt;br&gt;&amp;nbsp;&lt;br&gt;Most reactions are mild or moderate and are typically treated with acetaminophen, hydrocortisone, and diphenhydramine.&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Standard Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Notify Most Responsible Health Practitioner (MRHP)&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;- If adverse reaction, stop infusion and notify MRHP.&lt;br&gt;- Symptoms of an adverse reaction may include: Itching, hives (urticaria), headache, dizziness, flushing, and temperature greater than 1.5C above baseline, greater than 20mmHg change (up or down) in systolic blood pressure, chest discomfort, shortness of breath or stridor.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Standard Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Notify Most Responsible Health Practitioner (MRHP)&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Standard Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;inFLIXimab (Remicade) injection; *** mg (5 mg/kg/dose), intravenous, once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 10-250 mL/hr titrated. Start infusion rate at 10 mL/hr and slowly increase infusion rate by doubling rate every 15 minutes. After 1 hour, increase to 150 mL/hr for 30 minutes, then increase to 250 mL/hr until infusion complete.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Monitor for adverse reactions. Review the &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Patients who develop a reaction are most likely to do so in response to the first 2 to 3 infusions.&amp;nbsp;&lt;/p&gt;&lt;p&gt;-If adverse reaction, call MRHP, do vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;-Restart infusion at 10mL/hr, and resume titration schedule&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;NOTE: if severe reaction (blood pressure change greater than 40 mm/Hg up or down), wheezing, stridor, temperature with rigors, infusion will NOT be restarted&lt;/p&gt;&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Standard Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;inFLIXimab (Renflexis) injection; *** mg  (5 mg/kg/dose), intravenous, once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 10-250 mL/hr titrated. Start infusion rate at 10 mL/hr and slowly increase infusion rate by doubling rate every 15 minutes. After 1 hour, increase to 150 mL/hr for 30 minutes, then increase to 250 mL/hr until infusion complete.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Monitor for adverse reactions. Review the &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Patients who develop a reaction are most likely to do so in response to the first 2 to 3 infusions.&amp;nbsp;&lt;/p&gt;&lt;p&gt;-If adverse reaction, call MRHP, do vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;-Restart infusion at 10mL/hr, and resume titration schedule&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;NOTE: if severe reaction (blood pressure change greater than 40 mm/Hg up or down), wheezing, stridor, temperature with rigors, infusion will NOT be restarted&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Standard Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;inFLIXimab (Inflectra) injection; *** mg (5 mg/kg/dose), intravenous, once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 10-250 mL/hr titrated. Start infusion rate at 10 mL/hr and slowly increase infusion rate by doubling rate every 15 minutes. After 1 hour, increase to 150 mL/hr for 30 minutes, then increase to 250 mL/hr until infusion complete.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Monitor for adverse reactions. Review the &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Patients who develop a reaction are most likely to do so in response to the first 2 to 3 infusions.&amp;nbsp;&lt;/p&gt;&lt;p&gt;-If adverse reaction, call MRHP, do vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;-Restart infusion at 10mL/hr, and resume titration schedule&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;NOTE: if severe reaction (blood pressure change greater than 40 mm/Hg up or down), wheezing, stridor, temperature with rigors, infusion will NOT be restarted&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Standard Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Rapid Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Notify Most Responsible Health Practitioner (MRHP)&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;- If adverse reaction, stop infusion and notify MRHP&amp;nbsp;&lt;br&gt;- Symptoms of an adverse reaction may include: Itching, hives (urticaria), headache, dizziness, flushing, and temperature greater than 1.5C above baseline, greater than 20mmHg change (up or down) in systolic blood pressure, chest discomfort, shortness of breath or stridor.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Rapid Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Notify Most Responsible Health Practitioner (MRHP)&apos;]/activities[at0156]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Rapid Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;inFLIXimab (Remicade) injection; 5 mg/kg/dose, intravenous, once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 100-300 mL/hr titrated. Start infusion rate at 100mL/hr for 15 minutes, and then increase infusion rate to 300mL/hr until infusion complete.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Monitor for adverse reactions. Review the &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Patients who develop a reaction are most likely to do so in response to the first 2 to 3 infusions.&amp;nbsp;&lt;/p&gt;&lt;p&gt;-If adverse reaction, call MRHP, do vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;-Restart infusion at 10mL/hr, and resume titration schedule&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;NOTE: if severe reaction (blood pressure change greater than 40 mm/Hg up or down), wheezing, stridor, temperature with rigors, infusion will NOT be restarted&lt;/p&gt;&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Rapid Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;inFLIXimab (Renflexis) injection; 5 mg/kg/dose, intravenous, once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 100-300 mL/hr titrated. Start infusion rate at 100mL/hr for 15 minutes, and then increase infusion rate to 300mL/hr until infusion complete.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Monitor for adverse reactions. Review the &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Patients who develop a reaction are most likely to do so in response to the first 2 to 3 infusions.&amp;nbsp;&lt;/p&gt;&lt;p&gt;-If adverse reaction, call MRHP, do vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;-Restart infusion at 10mL/hr, and resume titration schedule&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;NOTE: if severe reaction (blood pressure change greater than 40 mm/Hg up or down), wheezing, stridor, temperature with rigors, infusion will NOT be restarted&lt;br&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Rapid Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;inFLIXimab (Inflectra) injection; 5 mg/kg/dose, intravenous, once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 100-300 mL/hr titrated. Start infusion rate at 100mL/hr for 15 minutes, and then increase infusion rate to 300mL/hr until infusion complete.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Monitor for adverse reactions. Review the &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Patients who develop a reaction are most likely to do so in response to the first 2 to 3 infusions.&amp;nbsp;&lt;/p&gt;&lt;p&gt;-If adverse reaction, call MRHP, do vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;-Restart infusion at 10mL/hr, and resume titration schedule&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;NOTE: if severe reaction (blood pressure change greater than 40 mm/Hg up or down), wheezing, stridor, temperature with rigors, infusion will NOT be restarted&lt;/p&gt;&lt;p&gt;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;inFLIXimab Rapid Infusion&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adalimumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;Adalimumab is restricted for the treatment of moderate to severely active Crohn&apos;s Disease in pediatric patients aged 13 to 17 years. It is subject to Specialized High-Cost Drug Program criteria of use.&lt;br&gt;Dosing regime is as follows:&lt;/p&gt;&lt;ul&gt;&lt;li&gt;First dose (initial) - 160 mg&lt;/li&gt;&lt;li&gt;Second dose (after two weeks) - 80mg&lt;/li&gt;&lt;li&gt;Third dose (four weeks from the initial dose) - 40 mg&lt;br&gt;&amp;nbsp;&lt;/li&gt;&lt;/ul&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adalimumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;adalimumab injection; 160 mg, subcutaneous, once&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Monitor for adverse reactions. Review &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adalimumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;adalimumab injection; 80 mg, subcutaneous, every 2 weeks, starting T+14 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Monitor for adverse reactions. Review &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adalimumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;adalimumab injection; 40 mg, subcuteous, every 2 weeks, starting T + 28 days&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Monitor for adverse reactions. Review &quot;Clinical Implications&quot; and &quot;Adverse Effects&quot; sections located in parenteral monograph for adverse reaction instructions.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adalimumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Adalimumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;ul&gt;&lt;li&gt;Ustekinumab is non-formulary, must use non-formulary process to order medication&lt;/li&gt;&lt;li&gt;Assess patient for contraindications to Ustekinumab IV/SC treatment:&lt;ul&gt;&lt;li&gt;Previous IV/SC treatment reaction or anaphylaxis to ustekinumab&lt;/li&gt;&lt;li&gt;Previous need for pre-medication for ustekinumab&lt;/li&gt;&lt;li&gt;Re-commencing ustekinumab after prolonged hiatus (greater than 10 weeks since last IV/SC treatment)&lt;br&gt;&amp;nbsp;&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;/ul&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; for adverse reaction&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;A. Stop the Infusion and notify MRHP stat&lt;br&gt;B. Vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;C. Restart infusion at 10mL/hr, and resume titration schedule&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Symptoms of an adverse reaction may include: Itching, hives (urticaria), headache, dizziness, flushing, and temperature greater than 1.5C above baseline, greater than 20mmHg change (up or down) in systolic blood pressure, chest discomfort, shortness of breath or stridor.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;NOTE: if severe reaction (blood pressure change greater than 40 mm/Hg up or down), wheezing, stridor, temperature with rigors, infusion will NOT be restarted&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab (weight less than or equal to 55 kg)&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab (weight less than or equal to 55 kg)&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Weight less than or equal to 55 kg. Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 52 mL volume to be withdrawn from a 250 ml IV bag of 0.9% sodium chloride to dilute the 260 mg Ustekinumab (2 vials required) IV solution dose. Infuse the diluted solution over a period of at least one hour.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab (weight greater than 55 kg to less than or equal to 85 kg)&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab (weight greater than 55 kg to less than or equal to 85 kg)&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Weight greater than 55 kg to less than or equal to 85 kg. Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 78 mL volume to be withdrawn from a 250 ml IV bag of 0.9% sodium chloride to dilute the 390 mg Ustekinumab (3 vials required) IV solution dose. Infuse the diluted solution over a period of at least one hour.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab (weight greater than 85 kg)&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab (weight greater than 85 kg)&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Weight greater than 85 kg. Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. 104 mL volume to be withdrawn from a 250 ml IV bag of 0.9% sodium chloride to dilute the 520 mg Ustekinumab (4 vials required) IV solution dose. Infuse the diluted solution over a period of at least one hour.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Ustekinumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vedolizumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;ul&gt;&lt;li&gt;Vedolizumab is a non-formulary medication, you must use a non-formulary process to order medication&lt;/li&gt;&lt;li&gt;Assess patient for contraindications to vedolizumab Infusion:&lt;ul&gt;&lt;li&gt;Previous infusion reaction or anaphylaxis to vedolizumab&lt;/li&gt;&lt;li&gt;Previous need for pre-medication for vedolizumab&lt;/li&gt;&lt;li&gt;Re-commencing vedolizumab after prolonged hiatus (greater than 10 weeks since last infusion)&lt;/li&gt;&lt;li&gt;Any new onset or worsening of neurological signs and symptoms where progressive multifocal leukoencephalopathy (PML) is suspected, treatment with vedolizumab must be withheld; if confirmed, treatment must be permanently discontinued.&lt;/li&gt;&lt;/ul&gt;&lt;/li&gt;&lt;li&gt;Most acute reactions occur within the first few hours of administration and are non-IgE mediated anaphylactic type reactions. Rare allergic reactions have also been reported. Delayed hypersensitivity reactions may occur 1 to 14 days after the infusion.&lt;/li&gt;&lt;li&gt;Most reactions are mild or moderate and are typically treated with acetaminophen, hydrocortisone, and diphenhydrAMINE.&lt;/li&gt;&lt;li&gt;Serious reactions are treated with EPINEPHrine.&lt;br&gt;&amp;nbsp;&lt;/li&gt;&lt;/ul&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vedolizumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Notify Most Responsible Health Practitioner (MRHP)&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;If adverse reactions, stop infusion and notify MRHP .&lt;br&gt;Symptoms of an adverse reaction may include: Itching, hives (urticaria), headache, dizziness, flushing, and temperature greater than 1.5C above baseline, greater than 20mmHg change (up or down) in systolic blood pressure, chest discomfort, shortness of breath or stridor.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vedolizumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; for Adverse Reaction&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;A. Stop the Infusion and notify MD stat&lt;br&gt;B. Vital signs every 5 minutes until normal; then wait 20 minutes before restarting&lt;br&gt;C. Restart infusion at 10mL/hr, and resume titration schedule&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;&lt;p&gt;Symptoms of an adverse reaction may include: Itching, hives (urticaria), headache, dizziness, flushing, and temperature greater than 1.5C above baseline, greater than 20mmHg change (up or down) in systolic blood pressure, chest discomfort, shortness of breath or stridor.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vedolizumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;Nursing Communication; for vedolizumab administration&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Use an in-line, sterile, non-pyrogenic, low protein-binding filter with 1.2-micron pore size or less. Give Vedolizumab over 30 minutes. Flush with 30 mL of Sodium Chloride 0.9% after the infusion is complete.&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Vedolizumab&apos;]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Emergency Medications&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;For high risk patients select the order: &quot;Emergency medications to be kept at bedside&quot;, medications will be pre-drawn&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Emergency Medications&apos;]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;At Bedside; Emergency medications to be kept at bedside&apos;]/activities[at0001]">
    <items>
      <item>
        <key>CKT.Content Details</key>
        <value>&lt;p&gt;Emergency medications should be pre-drawn&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Emergency Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;EPINEPHrine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children less than 30 kg&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Emergency Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;EPINEPHrine&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Children greater than or equal to 30 kg&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;Y&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Emergency Medications&apos;]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;EPINEPHrine&apos;]/items[openEHR-EHR-INSTRUCTION.section_supporting_context.v1]">
    <items>
      <item>
        <key>Transform.Preselected</key>
        <value>&lt;p&gt;N&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1 and name/value=&apos;Discharge Instructions&apos;]/items[openEHR-EHR-SECTION.clinical_guidance.v1]">
    <items>
      <item>
        <key>CKT.Clinical Guidance</key>
        <value>&lt;p&gt;- Ensure that a therapy plan is completed for Infliximab (Inflectra, Remicade or Renflexis) and for Vedolizumab.&amp;nbsp;&lt;br&gt;- For Ustekinumab a therapy plan is only needed if the patient decides to come to the day ward for their subcutaneous injections or rarely repeated infusion.&amp;nbsp;&lt;br&gt;&amp;nbsp;&lt;/p&gt;</value>
      </item>
    </items>
  </annotations>
  <definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Biologic Medications for GI Patients Pediatric">
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Patient Care">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Vital Signs">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3075bff7-28dd-4e96-816d-4cfddd0ee1d5" concept_name="PC Vital Signs Order" max="1" path="/items" name="Vital Signs; for Standard Infusion inFLIXimab (Inflectra, Remicade, and Renflexis), Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3075bff7-28dd-4e96-816d-4cfddd0ee1d5" concept_name="PC Vital Signs Order" max="1" path="/items" name="Vital Signs; for Rapid Infusion inFLIXimab (Inflectra, Remicade, and Renflexis), Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3075bff7-28dd-4e96-816d-4cfddd0ee1d5" concept_name="PC Vital Signs Order" max="1" path="/items" name="Vital Signs; for adalimumab, Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3075bff7-28dd-4e96-816d-4cfddd0ee1d5" concept_name="PC Vital Signs Order" max="1" path="/items" name="Vital Signs; for ustekinumab, Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3075bff7-28dd-4e96-816d-4cfddd0ee1d5" concept_name="PC Vital Signs Order" max="1" path="/items" name="Vital Signs; for vedolizumab, Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3075bff7-28dd-4e96-816d-4cfddd0ee1d5" concept_name="PC Vital Signs Order" max="1" path="/items" name="Vital Signs; if the patient had a previous infusion reaction, Per protocol"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Monitors">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d4e04fb8-68ce-46ce-a2c1-85186c0b4c5d" concept_name="PC Cardio_Respiratory Monitoring Order" max="1" path="/items" name="Cardio-respiratory Monitoring; off for tests and activities"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="d4e04fb8-68ce-46ce-a2c1-85186c0b4c5d" concept_name="PC Cardio_Respiratory Monitoring Order" max="1" path="/items" name="Cardio-respiratory Monitoring; NOT off for tests and activities"/>
      </Item>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Laboratory Investigations - Routine">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Hematology">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f278091d-c5d3-4390-9efe-fb00aa4551a3" concept_name="LAB CBC and Differential Order" max="1" path="/items" name="CBC and Differential; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="9ce6c04c-77ba-402d-832b-23b220e3d3e5" concept_name="LAB Erythrocyte Sedimentation Rate (ESR) Order" max="1" path="/items" name="Erythrocyte Sedimentation Rate (ESR); Once"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Chemistry">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="606f5158-5db6-4741-8014-b82c8bbc0fd7" concept_name="LAB C-Reactive Protein (CRP) Order" max="1" path="/items" name="C-Reactive Protein (CRP); Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="2c6afe38-0e28-4406-9cf5-1268b186d33e" concept_name="LAB Albumin Order" max="1" path="/items" name="Albumin; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="25f47bf0-23bc-4bad-9122-847f839ca10d" concept_name="LAB Alanine Aminotransferase (ALT) Order" max="1" path="/items" name="Alanine Aminotransferase (ALT); Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="134a5623-814e-4cc7-8079-5650fb98bf61" concept_name="LAB Aspartate Aminotransferase (AST) Order" max="1" path="/items" name="Aspartate Aminotransferase (AST); Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="de86cc5a-bd49-4c74-9c52-a05eea0aa482" concept_name="LAB Alkaline Phosphatase (ALP) Order" max="1" path="/items" name="Alkaline Phosphatase (ALP); Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fe96c45e-fd90-4e6c-82f5-94229430659e" concept_name="LAB Gamma Glutamyl Transferase (GGT) Order" max="1" path="/items" name="Gamma Glutamyl Transferase (GGT); Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e6a84102-272d-436d-8f44-a66fe48cec02" concept_name="LAB Bilirubin Total and Conjugated Order" max="1" path="/items" name="Bilirubin, Total and Conjugated; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="5984e421-785d-4aaa-9502-9c5b46216d95" concept_name="LAB Calcium Order" max="1" path="/items" name="Calcium; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1318381c-0ef3-41c6-8fd0-32cfca866727" concept_name="LAB Magnesium Order" max="1" path="/items" name="Magnesium; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="1ef469fe-549f-423f-aad5-51e073a25aef" concept_name="LAB Phosphate Order" max="1" path="/items" name="Phosphate; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="27648100-2257-4720-8632-4e5375db6232" concept_name="LAB Zinc Level, Serum Order" max="1" path="/items" name="Zinc Level, Serum; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="43f7b459-7c31-4bc7-9427-e1d9ccbe40f8" concept_name="LAB Selenium Level, Serum Order" max="1" path="/items" name="Selenium Level, Serum; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c4ad1219-1f34-4cb6-acda-93bd0e5e0a32" concept_name="LAB Folate Order" max="1" path="/items" name="Folate; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="643b43c8-1d78-44d0-9b48-4de3c44df284" concept_name="LAB Vitamin B12 Order" max="1" path="/items" name="Vitamin B12; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="c77ec2ba-b104-462b-9aea-2ccb9ae9885a" concept_name="LAB Ferritin Order" max="1" path="/items" name="Ferritin; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="f7843eda-b7e9-44b2-a5c1-a0942a275fb1" concept_name="LAB Iron and TIBC Order" max="1" path="/items" name="Iron and TIBC; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="73d8993c-cf48-4372-8204-c5f123539e86" concept_name="LAB 25-Hydroxy Vitamin D Order" max="1" path="/items" name="25-Hydroxy Vitamin D; Once"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Urine">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="384a2bd0-a6cd-4355-a421-a87822e31f2a" concept_name="LAB Urinalysis Order" max="1" path="/items" name="Urinalysis; Once"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Stool">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="8c93c776-ee29-4078-8ea0-a2ddc6615d96" concept_name="LAB Fecal Calprotectin (Referred Test) Order" max="1" path="/items" name="Fecal Calprotectin (Referred Test); Once, 1st stool of the day"/>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Therapeutic Drug Monitoring and Toxicology">
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="241d623b-5c3c-4060-a353-f3e8c999283c" concept_name="LAB Adalimumab Level Order" max="1" path="/items" name="Adalimumab Level (Referred Test); Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="471738c2-fdcf-4f46-abc3-90cef153d031" concept_name="LAB Infliximab Order" max="1" path="/items" name="Infliximab Level; Once"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="dac68834-4dcf-418e-81d9-50a52b0d82f2" concept_name="LAB Ustekinumab Order" max="1" path="/items" name="Ustekinumab (Referred Test); Once"/>
      </Item>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Fluids/Electrolytes">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="IV Maintenance">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" template_id="3d373e47-d398-4835-99e2-dfe7f379a335" concept_name="Insert and Maintain IV Pediatric Copy Template Order Group" max="1" path="/items" name="Insert and Maintain IV Pediatric"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Pediatric Topic Anesthetic Agents">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="0e29f686-4c87-405d-9d45-3d98c85c6f47" concept_name="PHARM tetracaine Gel 4% Order" max="1" path="/items" name="tetracaine Gel 4%; For ages 1 month of age and up"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="de239ed9-bf2c-4b0d-8e94-3c8f8419b5ce" concept_name="PHARM lidocaine-prilocaine Cream 2.5%-2.5% (Emla) Order" max="1" path="/items" name="lidocaine-prilocaine Cream 2.5%-2.5% (Emla); For ages 3 months of age and up"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7ccf14a3-fddd-4ca6-b3ee-ccaff2c335d2" concept_name="PHARM lidocaine, liposomal Cream 4% Order" max="1" path="/items" name="lidocaine, liposomal Cream 4%; For infants 1 month to 3 years of age"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="7ccf14a3-fddd-4ca6-b3ee-ccaff2c335d2" concept_name="PHARM lidocaine, liposomal Cream 4% Order" max="1" path="/items" name="lidocaine, liposomal Cream 4%; For children age 4 years and up"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="a1fe398b-f069-4cf4-9680-df004a6cffb3" concept_name="PHARM sucrose Oral liquid 24% Order" max="1" path="/items" name="sucrose Oral liquid 24%; for ages 0 to four months"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Medications">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Pre-Medications for Biologic Infusions">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="acetaminophen">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="35a11d27-b54e-4a3d-9e96-8988f1f0a13f" concept_name="PHARM acetaminophen liquid oral Order" max="1" path="/items" name="acetaminophen liquid oral; *** mg/kg/dose, oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR (linked order)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17eeb736-36ac-4e6f-81eb-b4969ac1e465" concept_name="PHARM acetaminophen Tablet Order" max="1" path="/items" name="acetaminophen Tablet; *** mg/kg/dose, oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Corticosteroids">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3543f7f3-765e-40d8-8cba-948dc77d4f56" concept_name="PHARM prednisoLONE sodium phosphate Oral liquid 1 mg/mL Order" max="1" path="/items" name="prednisoLONE sodium phosphate Oral liquid 1 mg/mL; *** mg (1 mg/kg/dose), oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration."/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ed859f75-e62d-4e33-91d8-c3c591f89101" concept_name="PHARM predniSONE Tablet Order" max="1" path="/items" name="predniSONE Tablet;  *** mg (1 mg/kg/dose), oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration."/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="76895ec7-b7e8-40b5-8ae3-28eb3b739e7c" concept_name="PHARM hydrocortisone sodium succinate injection Order" max="1" path="/items" name="hydrocortisone sodium succinate injection; *** mg (2 mg/kg/dose), intravenous, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration."/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="diphenhydrAMINE">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df7f878b-85c0-47ce-a50e-531ca3963b40" concept_name="PHARM diphenhydrAMINE injection Order" max="1" path="/items" name="diphenhydrAMINE injection; *** mg (1 mg/kg/dose), intravenous, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration."/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR (linked order)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ec2e26f3-d7a6-4824-993e-425902bce4a0" concept_name="PHARM diphenhydrAMINE Capsule Order" max="1" path="/items" name="diphenhydrAMINE Capsule; *** mg (25 mg/kg/dose), oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration."/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="cetirizine">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="e291a7f8-304b-4996-bae4-bd0898744b91" concept_name="PHARM cetirizine Oral liquid 1 mg/mL Order" max="1" path="/items" name="cetirizine Oral liquid 1 mg/mL; 5 mg, oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration."/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR (linked order)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="03598775-beba-4039-87cd-db82b478f155" concept_name="PHARM cetirizine Tablet Order" max="1" path="/items" name="cetirizine Tablet; 5 mg, oral, once, Administer oral pre-medications at least 15 minutes before Biologic medication administration."/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="inFLIXimab">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="inFLIXimab Standard Infusion">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="PC Notify Most Responsible Health practioner(MRHP) Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="48326509-c99c-4845-97df-41268d6029eb" concept_name="PHARM inFLIXimab (Remicade) injection Order" max="1" path="/items" name="inFLIXimab (Remicade) injection; *** mg (5 mg/kg/dose), intravenous, once"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="6bfd503d-c38b-434a-9306-4bf6f0741e2e" concept_name="PHARM inFLIXimab (Renflexis) injection Order" max="1" path="/items" name="inFLIXimab (Renflexis) injection; *** mg  (5 mg/kg/dose), intravenous, once"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="68c79ff2-d350-46bb-a23a-f94ff38af259" concept_name="PHARM inFLIXimab (Inflectra) injection Order" max="1" path="/items" name="inFLIXimab (Inflectra) injection; *** mg (5 mg/kg/dose), intravenous, once"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="inFLIXimab Rapid Infusion">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="PC Notify Most Responsible Health practioner(MRHP) Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="48326509-c99c-4845-97df-41268d6029eb" concept_name="PHARM inFLIXimab (Remicade) injection Order" max="1" path="/items" name="inFLIXimab (Remicade) injection; 5 mg/kg/dose, intravenous, once"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="6bfd503d-c38b-434a-9306-4bf6f0741e2e" concept_name="PHARM inFLIXimab (Renflexis) injection Order" max="1" path="/items" name="inFLIXimab (Renflexis) injection; 5 mg/kg/dose, intravenous, once"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="68c79ff2-d350-46bb-a23a-f94ff38af259" concept_name="PHARM inFLIXimab (Inflectra) injection Order" max="1" path="/items" name="inFLIXimab (Inflectra) injection; 5 mg/kg/dose, intravenous, once"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Adalimumab">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Adalimumab">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="PC Notify Most Responsible Health practioner(MRHP) Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP); If adverse reaction, call MRHP"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Adalimumab">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="cf77bb64-d222-42af-9c3d-859b77226941" concept_name="PHARM adalimumab injection Order" max="1" path="/items" name="adalimumab injection; 160 mg, subcutaneous, once"/>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Followed By (linked order)"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="cf77bb64-d222-42af-9c3d-859b77226941" concept_name="PHARM adalimumab injection Order" max="1" path="/items" name="adalimumab injection; 80 mg, subcutaneous, every 2 weeks, starting T+14 days"/>
            <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="(Followed By (linked order)"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="cf77bb64-d222-42af-9c3d-859b77226941" concept_name="PHARM adalimumab injection Order" max="1" path="/items" name="adalimumab injection; 40 mg, subcuteous, every 2 weeks, starting T + 28 days"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          </Item>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Ustekinumab">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Ustekinumab">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="PC Notify Most Responsible Health practioner(MRHP) Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP); If adverse reaction, stop the infusion and notify MRHP stat"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; for adverse reaction"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Ustekinumab (weight less than or equal to 55 kg)">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; Administration instructions for the ustekinumab 260 mg loading dose"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Ustekinumab (weight greater than 55 kg to less than or equal to 85 kg)">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; Administration instructions for the ustekinumab 390 mg loading dose"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Ustekinumab (weight greater than 85 kg)">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; Administration instructions for the ustekinumab 520 mg loading dose"/>
          </Item>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Vedolizumab">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Vedolizumab">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4e79ae6f-5402-4d96-b79f-68e943d8a4d2" concept_name="PC Notify Most Responsible Health practioner(MRHP) Order" max="1" path="/items" name="Notify Most Responsible Health Practitioner (MRHP)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; for Adverse Reaction"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ddd49576-2a7e-42d7-b258-bcb0b9b1a420" concept_name="PC Nursing Communication Order" max="1" path="/items" name="Nursing Communication; for vedolizumab administration"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Emergency Medications">
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="17543adf-583d-46d4-8b33-46db069480cf" concept_name="PC At Bedside Order" max="1" path="/items" name="At Bedside; Emergency medications to be kept at bedside"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="diphenhydraMINE">
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="df7f878b-85c0-47ce-a50e-531ca3963b40" concept_name="PHARM diphenhydrAMINE injection Order" max="1" path="/items" name="diphenhydrAMINE injection;  *** mg (1 mg/kg/dose), intravenous, every 4 hours, as needed for puritis"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR (linked order)"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="ec2e26f3-d7a6-4824-993e-425902bce4a0" concept_name="PHARM diphenhydrAMINE Capsule Order" max="1" path="/items" name="diphenhydrAMINE Capsule; 25 mg, oral, every 4 hours, as needed for puritis"/>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="OR (linked order) #1"/>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="577ce76d-eb5e-4b83-9620-3b6590e9f619" concept_name="PHARM diphenhydrAMINE Oral liquid 1.25 mg/mL Order" max="1" path="/items" name="diphenhydrAMINE Oral liquid 1.25 mg/mL; *** mg (1 mg/kg/dose), oral, every 4 hours, as neede for puritis"/>
        </Item>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="3da6e611-c8f1-449b-9dc4-e159d52b17a6" concept_name="PHARM salbutamol Inhaler 100 mcg/actuation Order" max="1" path="/items" name="salbutamol Inhaler 100 mcg/actuation; 4 puffs, inhalation, every 4 hours, as needed, bronchospasm, Administer via aero chamber"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="4ad170dc-0168-4a5e-b18d-b84496da37b8" concept_name="PHARM sodium chloride 0.9% bolus order" max="1" path="/items" name="sodium chloride 0.9% bolus; 20 mL/kg/dose, intravenous, once, as needed for allergic reaction, Administer over 30 minutes"/>
        <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="76895ec7-b7e8-40b5-8ae3-28eb3b739e7c" concept_name="PHARM hydrocortisone sodium succinate injection Order" max="1" path="/items" name="hydrocortisone sodium succinate injection; 2 mg/kgdose, intravenous, once, as needed for allergic reaction"/>
        <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="EPINEPHrine">
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Children less than 30 kg">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa679d55-957b-4ffb-a299-ad9f6f271cd5" concept_name="PHARM EPINEPHrine injection Order" max="1" path="/items" name="EPINEPHrine injection; 0.15 mg, once, as needed for anaphylaxis, STAT"/>
          </Item>
          <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Children greater than or equal to 30 kg">
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
            <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="fa679d55-957b-4ffb-a299-ad9f6f271cd5" concept_name="PHARM EPINEPHrine injection Order" max="1" path="/items" name="EPINEPHrine injection; 0.3 mg, intramuscular, once, as needed for anaphylaxis, STAT"/>
          </Item>
          <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1" concept_name="Section supporting context" path="/items"/>
        </Item>
      </Item>
    </Item>
    <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Discharge Instructions">
      <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
    </Item>
  </definition>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
    <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
    <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.adhoc_cluster_heading.v1">
    <digest id="MD5-CAM-1.0.1">B87630C57A2DB1AE21050E1105EDE18B</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
    <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1">
    <digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.section_supporting_context.v1">
    <digest id="MD5-CAM-1.0.1">A7EC4E4C870D8C3431B29F6514353416</digest>
  </integrity_checks>
  <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
    <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
  </integrity_checks>
</template>